ANALISIS KELANGSUNGAN HIDUP PASIEN DIABETES MELITUS TIPE 2 SELAMA 20 BULAN DI RUMAH SAKIT BHAYANGKARA DRS. TITUS ULLY
DOI:
https://doi.org/10.31004/prepotif.v8i2.30636Keywords:
analisis kelangsungan hidup, diabetes tipe 2, faktor risikoAbstract
Diabetes Melitus Tipe 2 (DMT2) adalah kondisi kronis sekaligus masalah kesehatan global yang signifikan. Indonesia, dengan 19,5 juta kasus diabetes pada tahun 2021, menempati peringkat kelima secara global, dan peringkat pertama dalam proporsi kasus yang belum terdiagnosa. Kelangsungan hidup individu dengan DMT2 sangat bergantung pada manajemen glikemik, penyakit penyerta, kepatuhan terapi, dan penyesuaian gaya hidup. Penelitian ini bertujuan untuk mengetahui faktor yang berpengaruh terhadap kelangsungan hidup pasien DMT2 di Rumah Sakit Bhayangkara Drs. Titus Ully selama periode 20 bulan. Metode dalam penelitian ini enggunakan desain kohort retrospektif, penelitian ini melibatkan semua pasien DMT2 yang berobat selama Januari 2021 hingga Januari 2022. Data diambil dari rekam medis dengan fokus pada variabel usia, jenis kelamin, kadar gula darah sewaktu (GDS), riwayat hipertensi, riwayat DMT2 pada keluarga, dan status kelangsungan hidup. Analisis kelangsungan hidup menggunakan metode Kaplan-Meier, sementara perbandingan diuji menggunakan Log-Rank. tidak memiliki riwayat hipertensi dan tidak memiliki riwayat DMT2 pada keluarga. Hasil observasi terhadap status kelangsungan hidup subjek menunjukkan bahwa 26,9% subjek berstatus sensor, sementara 70,1% subjek lainnya tetap hidup hingga akhir observasi. Dari analisis lima variabel yang berpengaruh terhadap kelangsungan hidup subjek DMT2, ditemukan nilai p untuk jenis kelamin (p=0,508), kelompok usia (p=0,957), kadar GDS (p=0,213), riwayat hipertensi (p=0,010*), dan riwayat DMT2 pada keluarga (p=0,030*). Kesimpulan yang didapatkan bahwa tingkat kelangsungan hidup pada pasien dengan DMT2 secara signifikan lebih rendah pada pasien dengan riwayat hipertensi dan riwayat penyakit T2DM pada keluarga.References
GBD 2019 Diabetes Mortality Collaborators (2022). Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. The lancet. Diabetes & endocrinology, 10(3), 177–192.
Gregg, E. W., Cheng, Y. J., Srinivasan, M., Lin, J., Geiss, L. S., Albright, A. L., & Imperatore, G. (2018). Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet (London, England), 391(10138), 2430–2440.
Gregg, E. W., Gu, Q., Cheng, Y. J., Narayan, K. M., & Cowie, C. C. (2007). Mortality trends in men and women with diabetes, 1971 to 2000. Annals of internal medicine, 147(3), 149–155.
Gregg, E. W., Sattar, N., & Ali, M. K. (2016). The changing face of diabetes complications. The Lancet Diabetes & Endocrinology, 4(6), 537–547.
Heald, A., Stedman, M., Robinson, A., Davies, M., Livingston, M., Alshames, R., Moreno, G., Gadsby, R., Rayman, G., Gibson, M., de Lusignan, S., & Whyte, M. (2022). Mortality rate associated with diabetes: Outcomes from a general practice level analysis in England using the Royal College of General Practitioners (RCGP) database indicate stability over a 15 year period. Diabetes Therapy, 13(3), 505–516.
Heald, A. H., Stedman, M., Laing, I., Gibson, M., & Whyte, M. (2023). Type 2 diabetes and mortality in females versus males in England: The salford diabetes cohort. Cardiovascular Endocrinology & Metabolism, 12(1).
Hermans, M. P., Ahn, S. A., & Rousseau, M. F. (2018). Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring. Journal of Diabetes, 11(4), 301–308.
International Diabetes Federation. (2021). IDF diabetes atlas, tenth. International Diabetes.
Iocara, S., Sava, E., Georgescu, O., Sirbu, A., Fica, S. (2018). Recent diabetes-related mortality trends in Romania. Acta Diabetologica, 55 (8): 821–826.
Leal, J., Gray, A. M., Clarke, P. M. (2009). Development of life-expectancy tables for people with diabetes type 2. Eur Heart J; 30 (7): 834–839.
Li, S., Wang, J., Zhang, B., Li, X., & Liu, Y. (2019). Diabetes Mellitus and Cause-Specific Mortality: A Population-Based Study. Diabetes & metabolism journal, 43(3), 319–341. https://doi.org/10.4093/dmj.2018.0060
Linkeviciute-Ulinskiene, D., Kaceniene, A., Dulskas, A., Patasius, A., Zabuliene, L., & Smailyte, G. (2020). Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania. International journal of environmental research and public health, 17(18), 6870.
Mahmudah, U., Surono, S., Prasetyo, P. W., Lola, M. S., Haryati, A.E. (2022). Cox proportional hazard regression survival analysis for type 2 diabetes melitus. Barekeng 16(1), 251-260
Rahman, R. S., Almomen, F., Alajmi, A. A., Asir, I., Basudan, S., Alenezi, M., Alabdulwahab, F., Al shammari, S., Aldakheel, A., Al Shehri, A., & Alabdulmohsen, M. (2022). Predictors and associated risk factors of development of type 2 diabetes mellitus. JOURNAL OF HEALTHCARE SCIENCES, 02(06), 100–105.
Rasooly, D., Yang, Q., Moonesinghe, R., Khoury, M. J., & Patel, C. J. (2022). The Joint Public Health Impact of family history of diabetes and cardiovascular disease among adults in the United States: A population-based study. Public Health Genomics, 25(5–6), 220–231.
Rueda, A. M., Ormond, M., Gore, M., Matloobi, M., Giordano, T. P., et al. (2010) Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia. J Infect 60: 99-105.
Saith, S. E., & Tang, J. (2016). All-cause mortality of high-normal random blood glucose using basic demographics. Journal of Cardiovascular Diseases & Diagnosis, 4(4).
Serbis, A., Giapros, V., Tsamis, K., Balomenou, F., Galli-Tsinopoulou, A., & Siomou, E. (2023). beta cell dysfunction in youth- and adult-onset type 2 diabetes: an extensive narrative review with a special focus on the role of nutrients. nutrients, 15(9), 2217.
Tatineni, M. B., & Vunnam, D. (2020). Anthropometric indices - Are they risk factors in young male subjects with family history of type II Diabetes? International Journal of Scientific Research, 9(3). https://doi.org/10.36106/ijsr
World Health Organization. (2016) Global report on diabetes 1–88. Available from: http://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=DE86065D8957A520439F6D8228C79DA1?sequence=1
Wu, H., Lau, E. S., Yang, A., Zhang, X., Fan, B., Ma, R. C., Kong, A. P., Chow, E., So, W.-Y., Chan, J. C., & Luk, A. O. (2023). Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong. PLOS Medicine, 20(1).
Yim, S., Malhotra, A. & Veves, A. (2007) “Antioxidants and CVD in diabetes: where do we stand now?,” Current Diabetes Reports, 7:1, 8–13
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Yaditta Mirdania, Ani Kusumadewi Akbar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
